A 2022 act reauthorized SBIR and STTR and added new checks

The record

On 30 September 2022, S.4900, titled the “SBIR and STTR Extension Act of 2022,” became Public Law No. 117-183, as Congress's own bill record shows. The enacted text, published by the Government Publishing Office as Public Law 117-183, does one narrow thing and several broader ones. Section 3 extends the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs' authorization by striking “2022” wherever it appears in the governing sections of the Small Business Act and inserting “2025.” Sections 4 and 5 are new: a foreign risk management regime requiring due-diligence covering cybersecurity practices, foreign ownership, foreign talent-recruitment participation and ties to named countries of concern, plus agency recovery authority for awards tainted by a material misstatement. The programs the Act extends operate under set-aside percentages of each agency's extramural R&D budget that SBA's own Policy Directive states reached 3.2 percent for SBIR in fiscal 2017 and 0.45 percent for STTR in fiscal 2016, and hold at those levels afterward.

What the documents establish

Congress's bill page is a status record, not an analysis: it fixes the date the bill became law and the public law number. The statute's own text is the evidence for what changed, and it establishes something a short label like “extension act” can undersell. Only Section 3 is a pure date swap; Sections 4 through 11 add disclosure, recovery, reporting and study obligations absent from the prior authorization. SBA's Policy Directive is a separate, living document stating the set-aside percentages the extended programs continue to apply; it does not derive from the 2022 Act, which reauthorized the charter rather than resetting that math. The two documents do different jobs: one sets a sunset date and new conditions, the other states an ongoing funding formula.

The operating read

For a founder reading a current SBIR or STTR solicitation, the reauthorization horizon in the statute's own text matters more than any agency's language about permanence. This is editorial, not a statement from the Act: a founder relying on a multi-year Phase I to Phase II runway should confirm, from current sources, whether authority has been extended again since fiscal 2025, since a lapse is a matter of statute, not agency preference. An applicant with a foreign joint venture, foreign ownership stake, technology licensed abroad in the last five years, or a foreign talent-program tie should expect a disclosure layer the pre-2022 statute did not specify.

What to check before you decide

Before treating an SBIR or STTR award timeline as settled, check the following:

• Has SBIR/STTR authorization been extended again past fiscal 2025, per the current congressional record?
• Does the participating agency's current extramural R&D budget and set-aside percentage match the figure being assumed for a given fiscal year?
• Does the applicant have any foreign ownership, joint venture, licensing history, or talent-program tie that Section 4's disclosure requirements would flag during review?

None of this is application advice; it describes what one statute and one agency directive state as of the dates each document carries. A solicitation's own terms, and the current state of the authorization, govern any actual application.